Pharmaceutical
Health
Therapy
Zogenix
$48.099876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$48.09
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.14 (0.29%) Today
$0.00 (0.00%) As of 4:06 PM EDT after-hours
Why Robinhood?
You can buy or sell Zogenix and other stocks, options, ETFs, and crypto commission-free!
About ZGNX
Zogenix, Inc. Common Stock, also called Zogenix, is a pharmaceutical compan. Read More It engages in the development and commercialization of central nervous system (CNS) therapies and products for the treatment orphan diseases and other CNS disorders. Its products include ZX008 and Relday. The company was founded by Stephen James Farr, Cam L. Garner, Roger L. Hawley, Bret E. Megargel, Jonathan M. N. Rigby, Scott L. Glenn, and John J. Turanin on May 11, 2006 and is headquartered in Emeryville, CA.
Employees
90
Headquarters
Emeryville, California
Founded
2006
Market Cap
2.04B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
346.65K
High Today
$48.44
Low Today
$47.75
Open Price
$47.89
Volume
294.97K
52 Week High
$59.85
52 Week Low
$33.43
Collections
Pharmaceutical
Health
Therapy
Technology
ZGNX News
Price Paid on Robinhood
25% Higher
Right Now
52 Week Low
$33.43
Average Price Paid
$38.40
52 Week High
$62.75
Analyst Ratings
90%
of 10 ratings
Buy
90%
Hold
10%
Sell
0%
ZGNX Earnings
-$1.17
-$0.96
-$0.74
-$0.53
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 6, After Hours